Mukherjee Ayan, Ramirez Danyel, Arora Rajat, Arthur Gilbert, Schweizer Frank
Department of Chemistry, University of Manitoba, Winnipeg, MB R3T 2N2, Canada.
Department of Chemistry, University of Manitoba, Winnipeg, MB R3T 2N2, Canada.
Bioorg Med Chem Lett. 2024 Jan 1;97:129371. doi: 10.1016/j.bmcl.2023.129371. Epub 2023 Jun 8.
Many antibiotics specific to Gram-positive bacteria like rifampicin (RIF) are inactive in Gram-negative bacteria because of outer membrane (OM) impermeability. Enhancing the OM permeability of these antibiotics with the help of OM perturbants is a promising strategy to develop new agents against Gram-negative bacteria. Here we report the synthesis and biological properties of amphiphilic tribasic galactosamines as potential RIF potentiators. Our results demonstrate that tribasic galactose-based amphiphiles potentiate RIF in multidrug-resistant Acinetobacter baumannii and Escherichia coli but not Pseudomonas aeruginosa in low salt-containing media. Under these conditions, lead compounds 20, 22 and 35 lowered the minimum inhibitory concentration of RIF by 64- to 256-fold against Gram-negative bacteria. However, the RIF-potentiating effect was reduced when bivalent Mg or Ca ions were added in the media at physiological concentrations. Overall, our results indicate that amphiphilic tribasic galactosamine-based compounds show reduced RIF-potentiating effects when compared to amphiphilic tobramycin antibiotics at physiological salt concentrations.
许多针对革兰氏阳性菌的抗生素,如利福平(RIF),由于外膜(OM)的不透性,在革兰氏阴性菌中无活性。借助外膜扰动剂提高这些抗生素的外膜通透性是开发抗革兰氏阴性菌新药物的一种有前景的策略。在此,我们报道了两亲性三元半乳糖胺作为潜在的利福平增效剂的合成及其生物学特性。我们的结果表明,基于三元半乳糖的两亲物在含低盐的培养基中可增强利福平对多重耐药鲍曼不动杆菌和大肠杆菌的活性,但对铜绿假单胞菌无此作用。在这些条件下,先导化合物20、22和35可使利福平对革兰氏阴性菌的最低抑菌浓度降低64至256倍。然而,当在培养基中添加生理浓度的二价镁或钙离子时,利福平增效作用会降低。总体而言,我们的结果表明,在生理盐浓度下,与两亲性妥布霉素抗生素相比,基于两亲性三元半乳糖胺的化合物显示出降低的利福平增效作用。